Hudson Pacific Properties: Q4 Earnings Insights

Hudson Pacific Properties (NYSE:HPP) reported its Q4 earnings results on Thursday, February 26, 2026 at 08:00 AM. Here’s what investors need to know about the announcement. Earnings Hudson Pacific Properties beat estimated earnings by 205.0%, reporting an EPS of...

Earnings Summary: Fate Therapeutics Q4

Fate Therapeutics (NASDAQ:FATE) just disclosed its Q4 earnings on Thursday, February 26, 2026 at 04:00 PM. Here’s a brief overview of the earnings report. Earnings Fate Therapeutics missed estimated earnings by 0.0%, reporting an EPS of $-0.27 versus an estimate...

A Look at Frontline’s Upcoming Earnings Report

Frontline (NYSE:FRO) is preparing to release its quarterly earnings on Friday, 2026-02-27. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect Frontline to report an earnings per share (EPS) of $1.02. Frontline...

Earnings Preview: Calumet Specialty Prods

Calumet Specialty Prods (NASDAQ:CLMT) is set to give its latest quarterly earnings report on Friday, 2026-02-27. Here’s what investors need to know before the announcement. Analysts estimate that Calumet Specialty Prods will report an earnings per share (EPS) of...

Argenx Touts Positive Phase 3 Eye Disease Study Results

Argenx SE (NASDAQ:ARGX) on Thursday announced positive topline results from the Phase 3 ADAPT OCULUS study evaluating VYVGART in adults with ocular myasthenia gravis (oMG). It is an autoimmune disorder where antibodies disrupt nerve-muscle communication, causing...

Preview: Globalstar’s Earnings

Globalstar (AMEX:GSAT) will release its quarterly earnings report on Friday, 2026-02-27. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate Globalstar to report an earnings per share (EPS) of $0.01. Globalstar bulls will hope to...

Earnings Outlook For Amneal Pharmaceuticals

Amneal Pharmaceuticals (NASDAQ:AMRX) will release its quarterly earnings report on Friday, 2026-02-27. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate Amneal Pharmaceuticals to report an earnings per share (EPS) of $0.18. The...

Minesto publishes Year-End Report 2025

GOTHENBURG, Sweden, Feb. 26, 2026 /PRNewswire/ — CEO Dr Martin Edlund: “A year of global brand and technology exposure and grid-connected electricity production with commercial-scale powerplant” Significant events October-December 2025 On 28 October,...